Wed, 05 Dec 2018 05:59:47 GMT
Takeda grants approval for $59B Shire takeover
Takeda Pharmaceutical shareholders have granted their approval on Wednesday for a $59B acquisition of the London-listed Shire, becoming one of the top ten drugmakers in the world, but also one of the most indebted.